08/08/2014 - 10:26am

Diplomat on Thursday announced that its president, Gary Kadlec, has been elected to the board of directors for the American Foundation of Pharmaceutical Education. 

08/04/2014 - 1:33pm

The Food and Drug Administration approved Lumizyme (alglucosidase alfa) for treatment of patients with infantile-onset Pompe disease, including patients who are younger than 8 years of age.

07/31/2014 - 7:17am

McKesson on Thursday reported revenues of $44.1 billion for the first quarter ended June 30, up 37%. 

07/28/2014 - 11:58am

The Food and Drug Administration on Monday expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17.

07/25/2014 - 11:25am

The National Association of Specialty Pharmacy  and the Specialty Pharmacy Association of America announced the merger of the two organizations, creating the largest professional and trade association focused on the unique needs in specialty pharmacy. 



07/24/2014 - 11:03am

Onco360, an independent oncology pharmacy and clinical support services company, announced that it has been selected to be part of the highly limited specialty pharmacy network of Zydelig tablets.

07/23/2014 - 12:02pm

The Food and Drug Administration on Wednesday announced approval for Zydelig (idelalisib) to treat patients with chronic lymphocytic leukemia, relapsed follicular B-cell non-Hodgkin lymphoma and relapsed small lymphocytic lymphoma.

07/21/2014 - 3:01pm

Illinois Gov. Pat Quinn signed a bill Monday that opens up medical marijuana to treat symptoms of epilepsy in adults and children.

07/21/2014 - 11:33am

AbbVie has finalized a deal for Dublin-based specialty pharmaceuticals company Shire for $54.7 billion.